Selection reflects international recognition for the potential of Cerebra digital technology to change the future of sleep analysis.

Cerebra is pleased to announce that California-based MedTech Innovator, the premier international nonprofit startup accelerator in the medical technology industry, has selected Cerebra Health to participate in the organization’s 2020 MedTech Innovator Accelerator program, featuring the most promising medical technologies from around the globe.

Cerebra was chosen for its unique technology platform for delivering in-depth sleep analysis, centered on its advanced, EEG-based sleep metrics. The program commences June 25, 2020, with the MedTech Innovator Summit, where leadership teams from 50 best-in-class start-up companies will collaborate with MedTech Innovator’s corporate partners to find solutions to common challenges and mechanisms to accelerate their technologies. They will be joined by investors, providers, payers, and industry stakeholders, including representatives from major U.S. federal agencies.  For the first time, this year’s two-day event will be hosted virtually.

Cerebra was one of 30 early-stage companies elected to participate in MedTech Innovator’s award-winning Accelerator program, in which high-potential medtech startups are matched with senior industry leaders to receive in-depth, customized mentorship and support.

Acceptance into the MedTech Accelerator program is not only a recognition of disruptive potential of our technology, “stated Dawson Reimer, CEO of Cerebra. “But more importantly, an invaluable opportunity to work with a network of leading investors, providers, payers and industry stakeholdersWe are honored to be among this distinguished group of innovating companies.” 

The selection itself is a distinction, as Cerebra was chosen from an applicant pool of 1000+ companies, from across Europe and North America, first to compete in one of seven regional, qualifying MedTech Innovator Pitch Events, and ultimately to be among the few selected for the Accelerator program. The Accelerator is a four month long virtual program, which will culminate with Cerebra’s presentation and participation at The MedTech Conference – the world’s leading event for the medtech industry (October 5-7, 2020, Toronto).  As an Accelerator company, Cerebra will compete for a spot as a finalist in the Medtech Innovator Competition, with the potential to receive the US$350,000 grand prize and the title of 2020 MedTech Innovator.

More information about the MedTech Innovator program can be found here.

About Cerebra  

Cerebra Health Inc. (Cerebra) is a digital health company focused on the delivery of advanced sleep analysis to in-home and clinic-based testing.  Cerebra’s world leading, EEG based metrics provide in-depth, diagnostic sleep assessment that enables the future of personalized sleep care.  Enterprise-level and personal access is provided by the Company’s unique diagnostic platform, that includes medical device software and the first lab-quality, self-applied home sleep system on the market.

Cerebra Medical, a wholly owned subsidiary of Cerebra Health, operates an ISO 13485:2016 certified Quality Management System for the design, development and manufacture of EEG sleep monitoring systems and medical device software for collection and analysis of physiological data recorded during sleep.  Cerebra Medical holds an MDSAP certificate in conformance with the requirements of Health Canada and FDA.

About MedTech Innovator 

Based in Los Angeles, Calif., MedTech Innovator is the premier nonprofit startup accelerator in the medical technology industry. Its mission is to improve the lives of patients by accelerating the growth of companies that are transforming the healthcare system. MedTech Innovator matches healthcare industry leaders with innovative early-stage and emerging growth medtech companies for mentorship and support. For more information about MedTech Innovator, visit https://medtechinnovator.org/ and follow @MedTechAwards on Twitter.    

For more information or to schedule an interview contact: 

Mary Fearon or Lindsay Glasspoole  

mary@arc.agency / lindsay@arc.agency  

416-738-9506